Literature DB >> 566473

The selection of wild-type revertants from methotrexate permeability mutants.

W Flintoff, L Saya.   

Abstract

In a previous report, we described the selection and partial characterization of three distinct classes of methotrexate (Mtx)-resistant Chinese hamster ovary cells (CHO) (1). Class I cells contained a structural alteration in dihydrofolate reductase. Class II cells showed a alteration affecting the permeability of the drug. Class III cells, selected from class I cells, had an increased activity of the altered enzyme. In the work described here, the sensitivity of these lines to the diaminopyrimidines has been investigated. Class I cells are as sensitive, class II cells are 5- to 10-fold more sensitive, and class III cells are 10- to 30-fold more resistant than wild-type cells. The increased sensitivity of the class II cells provided an opportunity to select for revertants of these mutants and such phentotypic wild-type revertant cells have been selected using one diaminopyrimidine, pyrimethamine. Such cells have drug sensitivities and permeability characteristics similar to wild-type cells. A second class has been identified which has wild-type drug sensitivities to the diaminopyrimidines but Mtx class II resistance to Mtx, and drug permeabilities characteristic of Mtx-resistant class II cells.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 566473     DOI: 10.1007/bf01538980

Source DB:  PubMed          Journal:  Somatic Cell Genet        ISSN: 0098-0366


  2 in total

1.  Complementation of a methotrexate uptake defect in Chinese hamster ovary cells by DNA-mediated gene transfer.

Authors:  T M Underhill; W F Flintoff
Journal:  Mol Cell Biol       Date:  1989-04       Impact factor: 4.272

2.  Conjugation of methotrexate to poly(L-lysine) increases drug transport and overcomes drug resistance in cultured cells.

Authors:  H J Ryser; W C Shen
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.